| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 09/23/2004 | WO2004080424A2 Methods and compositions for neurite outgrowth detection |
| 09/23/2004 | WO2004080418A2 Nucleic acid compounds for inhibiting angiogenesis and tumor growth |
| 09/23/2004 | WO2004080416A2 Animal model simulating neurologic disease |
| 09/23/2004 | WO2004080392A2 Kinase inhibitors and methods of use in screening assays and modulation of cell proliferation and growth |
| 09/23/2004 | WO2004080385A2 Compositions and methods for diagnosing and treating an inflammation |
| 09/23/2004 | WO2004080374A2 Diagnostics and therapeutics for diseases associated with phosphodi-esterase 1c (pde1c) |
| 09/23/2004 | WO2004080373A2 Diagnostics and therapeutics for diseases associated with g-protein coupled proteinase activated receptor 2 (par2) |
| 09/23/2004 | WO2004080372A2 Diagnostics and therapeutics for diseases associated with g-protein coupled proteinase activated receptor 4 (par4) |
| 09/23/2004 | WO2004080288A2 Post-translational modifications of proteins as regulatory switches |
| 09/23/2004 | WO2004080285A2 Amyloid plaque as a target for therapeutics that function by blocking or disrupting chitin synthesis or activity |
| 09/23/2004 | WO2004080283A2 Type 1 ryanodine receptor-based methods |
| 09/23/2004 | WO2004080273A2 Compositions and methods for diagnosing and treating prostate cancer |
| 09/23/2004 | WO2004080272A2 Use of the genes leprotl1 and ob-rgrp for the screening of active compounds for weight gain or loss or diabetes in human or animal subjects |
| 09/23/2004 | WO2004080271A2 Method for prognosticating the progress of breast cancer and compounds useful for prevention or treatment thereof |
| 09/23/2004 | WO2004080270A2 Diagnostics and therapeutics for diseases associated with phosphodiesterase 1b (pde1b) |
| 09/23/2004 | WO2004080166A1 Model animal for retinopathy |
| 09/23/2004 | WO2004080146A2 A marker system for characterizing undifferentiated human embryonic stem cells |
| 09/23/2004 | WO2004073591A3 Diagnostics and therapeutics for diseases associated with g-protein coupled receptor prostaglandin e2 ep2 (prostaglandin e2 ep2) |
| 09/23/2004 | WO2004067130A3 Method for separating and detecting at least one analyte in biological matrices |
| 09/23/2004 | WO2004066914A3 Variant integrin polypeptides and uses thereof |
| 09/23/2004 | WO2004065602B1 Method of identifying the epithelial-mesenchymal transition of mesothelial cells (emtmc) and identifying emtmc-modulating compounds, pharmaceutical compositions and use thereof in the diagnosis and treatment of diseases associated with emtmc |
| 09/23/2004 | WO2004063354A3 Compositions and methods for characterizing and regulating wnt pathways |
| 09/23/2004 | WO2004061413A3 Method and apparatus for separation of particles in a microfluidic device |
| 09/23/2004 | WO2004060052A3 Transgenic mice expressing human cd20 and/or cd16 |
| 09/23/2004 | WO2004057301A3 Isolation and confirmation of analytes from test devices |
| 09/23/2004 | WO2004055198A3 Device and method for in-line blood testing using biochips |
| 09/23/2004 | WO2004055052A3 Nucleic acid sequences for use as biomarker for damage to the intestinal epithilum |
| 09/23/2004 | WO2004052365A3 Inhibition of inflamation using alpha 7 receptor-binding cholinergic agonists |
| 09/23/2004 | WO2004050845A3 Methods of quantitation and identification of peptides and proteins |
| 09/23/2004 | WO2004048603A3 Coatings |
| 09/23/2004 | WO2004045381A3 Immunoassay device for diagnosing congestive heart failure |
| 09/23/2004 | WO2004044587A3 Diagnostics and therapeutics for diseases associated with human endothelial differentiation, sphingolipid g-protein-coupled receptor 5 (edg5) |
| 09/23/2004 | WO2004044555A3 Diagnosis of sepsis or sirs using biomarker profiles |
| 09/23/2004 | WO2004042405A3 Diagnostics and therapeutics for diseases associated with human g-protein coupled receptor 3 (gpr3) |
| 09/23/2004 | WO2004042390A3 Diagnostics and therapeutics for diseases associated with human phosphodiesterase 4b (pde4b) |
| 09/23/2004 | WO2004042388A3 Diagnostics and therapeutics for diseases associated with human phosphodiesterase 8a (pde8a) |
| 09/23/2004 | WO2004039842A3 Humanized tissue factor antibodies |
| 09/23/2004 | WO2004029575A3 Methods for diagnosing htlv-i-mediated diseases |
| 09/23/2004 | WO2004028444A3 Parathyroid hormone antagonists and uses thereof |
| 09/23/2004 | WO2004027377A3 Electroactive microspheres and methods |
| 09/23/2004 | WO2004025250A3 System and methods for electrophoretic separation of proteins on protein binding membranes |
| 09/23/2004 | WO2004024284A3 Method of purifying polypeptides by simulated moving bed chromatography |
| 09/23/2004 | WO2004018710A3 Diagnosis of chronic rejection |
| 09/23/2004 | WO2004016751A3 Methods of treating neurodegenerative diseases |
| 09/23/2004 | WO2004015391A3 Mass spectrometry-based identification of proteins |
| 09/23/2004 | WO2004009782A3 Methods for generating enhanced antibody-producing cell lines with improved growth characteristics |
| 09/23/2004 | WO2004007671A3 METHODS OF IDENTIFYING COMPOUNDS THAT MODULATE IL-4 RECEPTOR-MEDIATED IgE SYNTHESIS UTILIZING A CLLD8 PROTEIN |
| 09/23/2004 | WO2003106968A3 Test strip for detection of analyte and methods of use |
| 09/23/2004 | WO2003106621A3 Anti-igf-i receptor antibody |
| 09/23/2004 | WO2003105561A3 Method and devices for diagnosing and treating choroid plexus failure |
| 09/23/2004 | WO2003104479A3 Identification of inhibitors of mitosis |
| 09/23/2004 | WO2003103601A3 Methods of diagnosing & treating diabetes and insulin resistance |
| 09/23/2004 | WO2003102157A3 Synthetic antibody phage libraries |
| 09/23/2004 | WO2003100439A3 Receptor and screening methods |
| 09/23/2004 | WO2003100079A3 Method of analyzing proenzyme forms of prostate specific antigen in serum to improve prostate cancer detection |
| 09/23/2004 | WO2003094836A3 Methods and products for enhancing immune responses using imidazoquinoline compounds |
| 09/23/2004 | WO2003087815A3 Method for the identification of inhibitors of the binding of are-containing mrn a and an hur protein |
| 09/23/2004 | WO2003086175A3 Compositions and methods for the therapy and diagnosis of lung cancer |
| 09/23/2004 | WO2003086174A3 A new method for the diagnosis and prognosis of malignant diseases |
| 09/23/2004 | WO2003085096A3 Therapeutic polypeptides, nucleic acids encoding same, and methods of use |
| 09/23/2004 | WO2003076588A3 Multiplexed cell transfection using coded carriers |
| 09/23/2004 | WO2003072017A3 Macromolecular conjugates and processes for preparing same |
| 09/23/2004 | WO2003066819A3 A novel artemis/dna-dependent protein kinase complex and methods of use thereof |
| 09/23/2004 | WO2003063782A3 Kappa-pviia-related conotoxins as organ protectants |
| 09/23/2004 | WO2003056341A3 Method for the diagnosis of breast cancer diseases, associated peptides and the uses thereof |
| 09/23/2004 | WO2003029262A3 The human mob-5 (il-24) receptors and uses thereof |
| 09/23/2004 | WO2003021223A3 Methods for qualitative and quantitative analysis of cells and related optical bio-disc systems |
| 09/23/2004 | WO2003011209A8 Methods of sensitizing hepatocyte cell cultures to hepatitis infection, beads coated with hbv or hcv polypeptides and methods of using such beads to model viral infection or deliver substances into hepatocytes |
| 09/23/2004 | WO2002095003A3 Phytases, nucleic acids encoding them and methods for making and using them |
| 09/23/2004 | US20040187171 Expression vectors comprising nucleotide sequences coding cytokines for tissue specific expression and treatment of skin disorders |
| 09/23/2004 | US20040187169 Identifying genes which effect cardiac function after or during oxygen deprivation for imaging and measuring movements of the heart; fluorescent microscopy; animal model for human heart disease |
| 09/23/2004 | US20040186772 Measurement assisting device and measuring device using the same |
| 09/23/2004 | US20040186692 Determination of the age, identification and sealing of a product containing volatile components |
| 09/23/2004 | US20040186391 Gas monitoring system and sidestream gas measurement system adapted to communicate with a mainstream gas measurement system |
| 09/23/2004 | US20040186359 Afinity biosensor for monitoring biological process |
| 09/23/2004 | US20040186278 2-{5-[1-(5-carboxypentyl)-3,3-dimethyl-1,3-dihydro-2H-indol-2-ylidene]-3-cyano-1,3-pentadienyl}-1,3,3-trimethyl-3H-indolinium (mesocyano Cy5); for sequencing, microarrays, flow cytometry and proteomics |
| 09/23/2004 | US20040186277 Process for the preparation in pure form of the protease activating blood clotting factor VII, its proenzyme or a mixture of both proteins by means of ion-exchange chromatography |
| 09/23/2004 | US20040186275 Sarcomere binding polypeptide for use in diagnosis and treatment of diabetes and cardiomyopathies; diuretics; vasodilation; antiarrhythmic agents |
| 09/23/2004 | US20040186274 Methylation of histone h4 at arginine 3 |
| 09/23/2004 | US20040186273 Prion-binding ligands and methods of using same |
| 09/23/2004 | US20040186117 Marker |
| 09/23/2004 | US20040186080 Beta 2-adrenergic receptor agonists |
| 09/23/2004 | US20040186079 SCREENING FOR MODULATORS USEFUL FOR TREATMENT OF DEFECTS IN SIGNAL TRANSDUCTION; SELECTING MODULATORS, SCREENING FOR DISRUPTION OR ACTIVATION OF SIGNAL TRANSDUCTION ACTIVITY; gene therapy |
| 09/23/2004 | US20040186049 Inhibition of histone deacetylase as a treatment for cardiac hypertrophy |
| 09/23/2004 | US20040186044 Modulation of myelination by interaction with P75 and TRK receptors |
| 09/23/2004 | US20040185592 Biosensor matrix and method for making same |
| 09/23/2004 | US20040185577 Bioassay which utilizes rapid displacement of solvents under mild vacuum for use in detecting pesticides, proteins and hormones |
| 09/23/2004 | US20040185575 via analyzing matrix metalloenzyme/proteinase activity in follicular fluid; artificial insemination |
| 09/23/2004 | US20040185574 Obtention and analysis of odors from odor emitters |
| 09/23/2004 | US20040185570 Erythrocyte sedimentation rate (ESR) test measurement instrument of unitary design and method of using the same |
| 09/23/2004 | US20040185551 Self-contained assay device for rapid detection of biohazardous agents |
| 09/23/2004 | US20040185550 Biochemical analysis unit |
| 09/23/2004 | US20040185547 undergo ligand-mediated receptor dimerization; determined by x-ray diffraction |
| 09/23/2004 | US20040185546 enzyme inhibitor for selectin mediated binding events and methods of treating disease conditions using animal models; genetic engineering |
| 09/23/2004 | US20040185536 Methods for differentiating and monitoring parathyroid and bone status related diseases |
| 09/23/2004 | US20040185533 Corticotropin-releasing factor2 receptors |
| 09/23/2004 | US20040185528 Method for improved protein expression in bacteria by monitoring and modulating protein folding |
| 09/23/2004 | US20040185519 Calcium-independent phospholipase A2 induces ischemic ventricular arrhythmias and decreases infarction size |
| 09/23/2004 | US20040185518 Excitation ratiometric fluorescent biosensor for zinc ion at picomolar levels |
| 09/23/2004 | US20040185517 Reaction side of which has polymer which increases opacity; acrylic latex, polystyrene sodium sulfate; reagent comprising a color indicator system (3-phenylimino-3H-phenothiazines and 3-phenylimino-3H-phenoxazines) |